The Hematology/Oncology Pharmacy Association (HOPA) has joined forces with several fellow medical associations and organizations to speak out against the immense proposed cuts to the future of cancer care, medical research, and health care in the United States.

HOPA recently added its voice to multiple letters advocating for Congress to reject the drastic, wide-ranging health care cuts found in the proposed Fiscal Year 2026 budget. These cuts - which include up to $700 billion from Medicaid, $18 billion from the National Institutes of Health, the elimination of the Grad PLUS loan program, and more - will harm the future of our nation's pharmacist workforce, put people's health care at risk, and set back our country's progress in the fight against cancer.

To help combat these proposed cuts, HOPA has signed the following advocacy letters and statements:

To read these statements in full - as well as other recent advocacy letters backed by HOPA - visit the sign-on letters page in HOPA's Press Room.

HOPA is proud to join these fellow groups in speaking out against these substantial, harmful cuts. Our voices are only stronger together. And to add your individual voice to these calls to reject the current budget cuts, visit HOPA's Legislative Action Center, which features easy-to-use tools for sharing your story, perspective, and advocacy with elected officials.

Together we can save cancer care - and lives.

Advocacy

End Cancer Drug Shortages Coalition: A Consensus Statement on Drug Shortages

HOPA has spearheaded a multi-year initiative with 16 other organizations to establish the consensus for combating cancer drug shortages. The statement outlines the major factors contributing to this crisis, and recommends policy solutions.

HOPA logo
Advocacy

HOPA Issues Updated Drug Shortages Brief

Shortages of drugs that are essential for the treatment and care of individuals with cancer result in compromises to patient care and, ultimately, outcomes.

An oncology pharmacist helping a patient
Advocacy

Oncology Pharmacist Survey: Understanding Task Value and Professional Satisfaction

Recent publications have explored workload and productivity to improve oncology pharmacy practice. HOPA aimed to build upon that research by assessing task valuation.